{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:29:59Z","timestamp":1792553399107,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26293062"],"award-info":[{"award-number":["26293062"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02610"],"award-info":[{"award-number":["18H02610"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K19373"],"award-info":[{"award-number":["21K19373"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02679"],"award-info":[{"award-number":["21H02679"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaut.2024.103245","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T06:09:23Z","timestamp":1715753363000},"page":"103245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody"],"prefix":"10.1016","volume":"146","author":[{"given":"Chizuru","family":"Akatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsuneshige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Numoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Uchiumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatake","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-1258","authenticated-orcid":false,"given":"Takeshi","family":"Tsubata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103245_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0000000000000922","article-title":"An update on autoantibodies in systemic lupus erythematosus","volume":"35","author":"Gomez-Banuelos","year":"2023","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103245_bib2","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2024.103245_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103245_bib4","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic lupus: a developing paradigm of disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103245_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.12688\/f1000research.10583.1","article-title":"B-cell tolerance and autoimmunity","volume":"6","author":"Tsubata","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.jaut.2024.103245_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103245_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.immuni.2013.12.014","article-title":"Autoimmune disorders associated with gain of function of the intracellular sensor MDA5","volume":"40","author":"Funabiki","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103245_bib9","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.39110","article-title":"Brief report: IFIH1 mutation causes systemic lupus erythematosus with selective IgA deficiency","volume":"67","author":"Van Eyck","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103245_bib10","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.4049\/jimmunol.1202195","article-title":"B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice","volume":"189","author":"Hwang","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.immuni.2012.11.017","article-title":"Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus","volume":"38","author":"Teichmann","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103245_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imr.13059","article-title":"Role of inhibitory B cell co-receptors in B cell self-tolerance to non-protein antigens","volume":"307","author":"Tsubata","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2024.103245_bib13","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/hmg\/ddh318","article-title":"CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B","volume":"13","author":"Hitomi","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2024.103245_bib14","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/1521-4141(200007)30:7<2027::AID-IMMU2027>3.0.CO;2-S","article-title":"Genetic dissection of vasculitis in MRL\/lpr lupus mice: a novel susceptibility locus involving the CD72c allele","volume":"30","author":"Qu","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib15","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1002\/art.23812","article-title":"Modulation of peripheral B cell tolerance by CD72 in a murine model","volume":"58","author":"Li","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103245_bib16","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.4049\/jimmunol.1203576","article-title":"Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease","volume":"190","author":"Xu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/antib5010002","article-title":"Autoantibodies in SLE: specificities, isotypes and receptors","volume":"5","author":"Dema","year":"2016","journal-title":"Antibodies"},{"key":"10.1016\/j.jaut.2024.103245_bib18","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1084\/jem.20160560","article-title":"CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm\/RNP","volume":"213","author":"Akatsu","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103245_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.20050630","article-title":"RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement","volume":"202","author":"Lau","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103245_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103245_bib21","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/anr.1780321010","article-title":"Antiribosomal S10 antibodies in humans and MRL\/lpr mice with systemic lupus erythematosus","volume":"32","author":"Bonfa","year":"1989","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103245_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.162.2.459","article-title":"Lupus autoantibodies target ribosomal P proteins","volume":"162","author":"Elkon","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103245_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0006-291X(90)90700-W","article-title":"Autoantibodies specific for the 20-KDal ribosomal large subunit protein L12","volume":"172","author":"Sato","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2024.103245_bib24","first-page":"1681","article-title":"Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease","volume":"18","author":"Sato","year":"1991","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103245_bib25","first-page":"139","article-title":"Autoantibody against ribosomal protein L14 in patients with systemic lupus erythematosus","volume":"20","author":"Hasegawa","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103245_bib26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/rheumatology\/kead402","article-title":"Pathogenetic associations of anti-ribosomal P protein antibody titres and its subclasses in patients with systemic lupus erythematosus","volume":"63","author":"Kaneko","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2024.103245_bib27","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/art.39081","article-title":"Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model","volume":"67","author":"Segovia-Miranda","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103245_bib28","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4049\/jimmunol.2000260","article-title":"Mood disorder in systemic lupus erythematosus induced by antiribosomal P protein antibodies associated with decreased serum and brain tryptophan","volume":"206","author":"Cho","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib29","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1126\/science.272.5268.1649","article-title":"A quasi-monoclonal mouse","volume":"272","author":"Cascalho","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jaut.2024.103245_bib30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib31","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103245_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103245_bib33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaut.2024.103245_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0076-6879(79)60062-9","article-title":"Polypeptide chain elongation factors from pig liver","volume":"60","author":"Iwasaki","year":"1979","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jaut.2024.103245_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/cei.12460","article-title":"Characterization of anti-P monoclonal antibodies directed against the ribosomal protein-RNA complex antigen and produced using Murphy Roths large autoimmune-prone mice","volume":"179","author":"Sato","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib36","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.171.4.1835","article-title":"Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells","volume":"171","author":"Hokazono","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jaut.2024.103245_bib38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.187.8.1343","article-title":"A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals","volume":"187","author":"Nishizumi","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103245_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1084\/jem.187.5.807","article-title":"Inhibition of the B cell by CD22: a requirement for Lyn","volume":"187","author":"Smith","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2024.103245_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1159\/000363449","article-title":"Termination of immune activation: an essential component of healthy host immune responses","volume":"6","author":"Kane","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.jaut.2024.103245_bib41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4049\/jimmunol.164.3.1223","article-title":"CD72 negatively regulates signaling through the antigen receptor of B cells","volume":"164","author":"Adachi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.1702903","article-title":"Association of B cell antigen receptor with protein tyrosine kinase Lyn","volume":"251","author":"Yamanashi","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jaut.2024.103245_bib43","doi-asserted-by":"crossref","first-page":"28136","DOI":"10.1016\/S0021-9258(18)46905-0","article-title":"Interactions of Lyn with the antigen receptor during B cell activation","volume":"269","author":"Burg","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2024.103245_bib44","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4049\/jimmunol.163.3.1321","article-title":"CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells","volume":"163","author":"Katagiri","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103245_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/368070a0","article-title":"A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling","volume":"368","author":"Muta","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103245_bib46","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1038\/s41598-020-65851-y","article-title":"Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes","volume":"10","author":"Badal","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2024.103245_bib47","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","article-title":"Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus","volume":"77","author":"Kato","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103245_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000322375","article-title":"CD22 regulates adaptive and innate immune responses of B cells","volume":"3","author":"Kawasaki","year":"2011","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.jaut.2024.103245_bib49","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3389\/fimmu.2018.00820","article-title":"CD22-Binding synthetic sialosides regulate B lymphocyte proliferation through CD22 ligand-dependent and independent pathways, and enhance antibody production in mice","volume":"9","author":"Matsubara","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:19:24Z","timestamp":1777580364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":49,"alternative-id":["S0896841124000799"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103245","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103245"}}